Appointment of New Members for Test Development and Advisory Committees
New Members for Test Development and Advisory Committees
TAMPA, Fla., February 19, 2026 – The American Board of Pathology (ABPath) is pleased to announce the appointment of the following new members to the ABPath’s Test Development and Advisory Committees (TDACs) beginning in 2026. The TDACs are responsible for developing and reviewing the ABPath certification exam questions that assess and certify a physician’s education, knowledge, experience, and skills in order to provide high-quality care in the pathology profession.
Maria Westerhoff, MD — Anatomic Pathology
Andrew Turk, MD — Anatomic Pathology
David Grier, MD — Anatomic Pathology – ABPath CertLink
Jonathan Lucas, MD — Anatomic Pathology – ABPath CertLink
Phillip Katzman, MD — Anatomic Pathology – ABPath CertLink
Gulisa Turashvili, MD — Anatomic Pathology – ABPath CertLink
Ryan Metcalf, MD — Blood Banking / Transfusion Medicine
William Phipps, MD — Chemical Pathology
Derek Allison, MD — Cytopathology
Shira Ronen, MD — Dermatopathology
Karolyn Wanat, MD — Dermatopathology
Reade Quinton, MD — Forensic Pathology
Robert Hasserjian, MD — Hematopathology
Geoffrey Wool, MD — Hematopathology
Matthew Hanna, MD — Management and Informatics
David Peaper, MD — Medical Microbiology
Noah Brown, MD — Molecular Genetic Pathology
Kristy Crooks, PhD — Molecular Genetic Pathology
Karra Jones, MD — Neuropathology
Portia Kreiger, MD — Pediatric Pathology
To be appointed to a TDAC means a physician is an established subject matter expert in their subspecialty field and is current on the latest advances in pathology and patient care. TDAC members develop and review examination questions for statistical performance and relevance to current practice, contribute to the validity of examinations by determining the content and exam blueprints and advise ABPath on issues in their area of expertise.
“The members of our Test Development and Advisory Committees are experts in their respective fields,” said Gary W. Procop, MD, MS, MEd, CEO of the American Board of Pathology. “They are instrumental in assessment development, the setting of standards, and in providing guidance on the current state of pathology. Appointment to a test committee is a recognition of an individual’s expertise, and their contributions help ensure the integrity and relevance of board certification.”
Since 1971, the ABPath has appointed test committees for each specialty area of pathology. The committee consists of ABPath trustees and other pathologists or specialty physicians who are recognized experts in their respective disciplines. There are presently 14 ABPath TDACs. They are: Anatomic Pathology, Anatomic Pathology CertLink®, Blood Banking/Transfusion Medicine, Chemical Pathology, Clinical Pathology CertLink®, Management and Informatics, Cytopathology, Dermatopathology (with appointees from the American Board of Dermatology), Forensic Pathology, Hematopathology, Medical Microbiology, Molecular Genetic Pathology (with appointees from the American Board of Medical Genetics and Genomics), Neuropathology, and Pediatric Pathology.
A complete list of ABPath committee members can be found here.
About the American Board of Pathology
The mission of the American Board of Pathology, as a member of the American Board of Medical Specialties, is to serve the public and advance the profession of pathology by setting certification standards and promoting lifelong competency of pathologists. Founded in 1936, the ABPath accomplishes this mission by establishing certification and continuing certification standards and assessing the qualifications of those seeking to obtain voluntary certification in the specialty of pathology. For more information visit abpath.org or call (813) 286-2444.